Daniel Ferry
Managing Director, Lifestyle Advisors
Replay available
CorMedix Inc. (CRMD) Q2 2025 Earnings Call
CorMedix Inc. (NASDAQ: CRMD) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joe Sidisco
Chief Executive Officer
Dr. Matt Damon
Executive Vice President and Chief Financial Officer
Anish Anfiliou
Analyst, RBC Capital Markets
Jason Butler
Analyst, Citizens
Councilman Leskoski
Analyst, Truist Securities
Brandon Foulkes
Analyst, ACU EnRite
Constant Search Bellinger
Analyst, Needham & Company
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cormedix Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:02.540 Good day and welcome to the Core Medics Inc. 00:00:02.540 -- 00:00:06.500 Second Quarter 2025 Financial Results Conference Call. 00:00:06.500 -- 00:00:09.140 All participants will be in listen-only mode. 00:00:09.140 -- 00:00:12.580 Should you need assistance, please email conference specialist by pressing the star key 00:00:12.580 -- 00:00:14.480 followed by zero. 00:00:14.480 -- 00:00:17.800 After today's presentation, there will be an opportunity to ask questions. 00:00:17.800 -- 00:00:21.400 To ask a question, you may press star then one on your telephone keypad. 00:00:21.400 -- 00:00:23.860 To draw your question, please press star then two. 00:00:23.860 -- 00:00:27.920 Please note this event is being recorded. Now I'll turn the conference over to Daniel 00:00:27.920 -- 00:00:30.180 Ferry, Managing Director of Lifestyle Advisors. 00:00:30.180 -- 00:00:32.460 Please go ahead. 00:00:32.740 -- 00:00:36.520 Good morning and welcome to the Core Medics Second Quarter 2025 Earnings and Corporate 00:00:36.520 -- 00:00:41.120 Update Conference Call. Leading the call today is Joe Sidisco, Chief Executive Officer 00:00:41.120 -- 00:00:46.780 of Core Medics. And he is joined by Dr. Matt Damon, Executive Vice President of CFO. 00:00:46.780 -- 00:00:52.160 In addition, Beth Zelnick-Kaufman, EVP and Chief Legal and Compliance Officer. 00:00:52.160 -- 00:00:56.560 Liz Hurlburt, EVP and Chief Clinical Strategy and Operations Officer. 00:00:56.560 -- 00:01:01.640 And Erin Mystery, EVP and Chief Commercial Officer are on the line and will 00:01:01.640 -- 00:01:05.120 be available during the Q&A session. 00:01:05.120 -- 00:01:08.440 Before we begin, I would like to remind everyone that during the call, management may 00:01:08.440 -- 00:01:12.140 m...